Cognitive impairment is prevalent in multiple sclerosis (MS) occurring in 43-72 % of patients with all MS phenotypes. The aim of our study was to assess cognitive performance in different MS subtypes in Serbian population. Rao's Brief Repeatable Battery of neuropsychological tests (BRB-N) was administered to 168 MS patients [37 patients with clinically isolated syndrome (CIS) suggestive of MS, 65 with relapsing-remitting MS (RRMS), 31 with secondary progressive MS (SPMS) and 35 patients with primary progressive MS (PPMS)]. The percentage of cognitively impaired patients in our total MS cohort was 58.9 %. Prevalence of cognitive dysfunction was 40.5 % in CIS group, 36.9 % in RRMS, 96.8 % in SPMS, and 85.7 % in PPMS group. Patients in CIS and RRMS groups performed consistently better all tests of the Rao's battery than patients in SPMS and PPMS cohort. CIS and RRMS groups performed consistently better in all tests of the Rao's battery than SPMS and PPMS cohort. Additionally, difference in the performance of any of the BRB-N tests was not found between CIS and RRMS. However, there was a significant difference between SPMS and PPMS patients in the performance on five tests of Rao's battery. Statistical significance (p < 0.05) in favor of PPMS patients was demonstrated for the following tasks: SRT_lts, SRT_cltr, SDMT, SRT_D, SPART_D. Our study demonstrates that cognitive impairment is frequent in all MS phenotypes. Furthermore, we have found that cognitive deficit is most severe and most frequent in SPMS patients, followed by PPMS subjects and then CIS and RRMS patients.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10072-016-2610-1DOI Listing

Publication Analysis

Top Keywords

cis rrms
12
tests rao's
12
rao's battery
12
spms ppms
12
rao's repeatable
8
repeatable battery
8
multiple sclerosis
8
serbian population
8
patients
8
rrms groups
8

Similar Publications

Beyond the Stroke: A Case Report of Multiple Sclerosis.

Cureus

November 2024

Department of Anaesthetics and Intensive Treatment Unit (ITU), Birmingham Heartlands Hospital, Birmingham, GBR.

Multiple sclerosis is an inflammatory, autoimmune demyelinating condition and poses diagnostic challenges due to varied presentations. This case report presents a divergence from typical clinical presentations of multiple sclerosis (MS), as the initial presentation resembled symptoms of a brain stem stroke. Conventionally, MS suspicion arises in the presence of previous neurological deficits or signs of optic neuritis.

View Article and Find Full Text PDF

Self-reports by persons with multiple sclerosis are an adequate surrogate for healthcare provider data on disease-modifying therapy and multiple sclerosis type.

Mult Scler Relat Disord

October 2023

Epidemiology, Biostatistics and Prevention Institute, University of Zurich (UZH), Zurich, Switzerland; Institute for Implementation Science in Health Care, University of Zurich (UZH), Zurich, Switzerland. Electronic address:

Introduction: Self-reports are a valuable and cost-effective method of data collection, though they can be influenced by bias. Limited evidence exists on the quality of self-reports by persons with multiple sclerosis (pwMS), particularly since more potent disease-modifying therapies (DMTs) have been introduced. This study aimed to assess the reliability and validity of self-reported DMT use and multiple sclerosis (MS) type in the Swiss Multiple Sclerosis Registry (SMSR) by comparing self-reports with reimbursement approval requests from the Swiss Association for Joint Tasks of Health Insurers.

View Article and Find Full Text PDF
Article Synopsis
  • Interferon-beta (IFN-β) remains crucial for managing multiple sclerosis (MS), with pegylated (PEG) IFN-β offering less frequent dosing for patients with relapsing-remitting MS (RRMS).
  • A study examined laboratory results and side effects between two forms of IFN-β treatment (PEG-IFN-β-1a and IFN-β-1a) among patients with clinically isolated syndrome (CIS) or RRMS over nine years.
  • Findings indicated that PEG-IFN-β-1a led to lower leukocyte counts and higher rates of leukopenia and neutropenia compared to IFN-β-1a, though both treatments had similar disease activity outcomes
View Article and Find Full Text PDF

Background: Individuals who are newly diagnosed with clinically isolated syndrome (CIS) or relapsing-remitting multiple sclerosis (RRMS) may choose not to undergo disease-modifying therapies (DMTs) due to concerns about expenses or potential adverse effects. Thus, many individuals will opt for alternative therapies, such as dietary modifications. Among these dietary approaches, the modified Paleolithic elimination diet has shown promise for improving MS-related symptoms; however, restriction of certain food groups can lead to inadequate intake of nutrients.

View Article and Find Full Text PDF

Biomarkers of tau phosphorylation state are associated with the clinical course of multiple sclerosis.

Mult Scler Relat Disord

October 2024

Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, University of Gothenburg, Gothenburg 413 45, Sweden; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal 431 80, Sweden; Paris Brain Institute, ICM, Pitié-Salpêtrière Hospital, Sorbonne University, Paris 75013, France; Neurodegenerative Disorder Research Center, Division of Life Sciences and Medicine, and Department of Neurology, Institute on Aging and Brain Disorders, University of Science and Technology of China and First Affiliated Hospital of USTC, Hefei 230001, PR China.

Article Synopsis
  • Research reveals that abnormal tau phosphorylation is detectable in the cerebrospinal fluid (CSF) of multiple sclerosis (MS) patients, particularly those with progressive forms of the disease.
  • A novel immunoassay technique was employed to analyze p-tau biomarkers in CSF samples from MS patients and those with non-inflammatory neurological disorders.
  • Results indicated higher levels of specific p-tau biomarkers in patients with progressive MS compared to those with relapsing forms, correlating with disease duration, age, and MRI lesion load.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!